Effect of recombinant human erythropoietin and its combination with tamoxifen on viability of MCF-7 cell in three-dimensional culture
Anemia is often a side-effect of cancers. Erythropoietin (EPO) is the erythropoiesisstimulating hormone produced by the kidneys that is used in the treatment of anemias. This hormone is being used concurrently with chemotherapeutic drugs in the treatment of cancers. From previous studies, EPO alo...
Saved in:
Main Author: | Shujaaedin, Hareth Yahya Ahmed |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2019
|
Subjects: | |
Online Access: | http://psasir.upm.edu.my/id/eprint/99228/1/IB%202021%203%20IR.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of tamoxifen-loaded erythropoietin-coated nanostructured lipid carrier on breast cancer cells and rat mammary gland tumour
by: Beh, Chaw Yee
Published: (2019) -
Characterisation and expression optimisation of recombinant human erythropoietin produced in the methylotrophic yeast pichia pastoris /
by: Teh, Ser Huy
Published: (2011) -
Relationship between erythropoietin and hepcidin among transfused Malaysian adult thalassemic patients
by: Ibraheem, Shahad Mohammed
Published: (2022) -
Erythropoietin and erythropoiesis in fetal and neonatal sheep /
by: Lim, Gaik Bee
Published: (1996) -
Regulation of erythropoietin messenger RNA /
by: Tan, Chorh Chuan
Published: (1992)